NCT05989594

Brief Summary

A two-parallel, evaluator-blind, single-center, randomized controlled trial was designed to assess the effectiveness of a home-based mobile guided exercise-based cardiac rehabilitation among patients undergoing Transcatheter Aortic Valve Replacement.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
18 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

August 14, 2023

Status Verified

August 1, 2023

Enrollment Period

7 months

First QC Date

August 3, 2023

Last Update Submit

August 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in 6-minute Walk Distance

    Distance walked in 6 minutes

    Month 3

Secondary Outcomes (3)

  • Change in 6-minute Walk Distance

    Month 6

  • Change in Short Physical Performance Battery (SPPB)

    Month 3 and Month 6

  • Exercise Adherence Assessed by the Exercise Adherence Rating Scale (EARS)

    Month1, Month 3 and Month 6

Other Outcomes (27)

  • All-cause Rehospitalizations and death

    Month 3 and Month 6

  • Handgrip Strength

    Month 3 and Month 6

  • Frailty Status Assessed by the Fried Frailty Criteria

    Month 3 and Month 6

  • +24 more other outcomes

Study Arms (2)

The REHAB-TAVR group

ACTIVE COMPARATOR

For the REHAB-TAVR group, discharge preparation will involve an exercise endurance test, exercise prescription guidance, motivational interviews, instruction on telerehabilitation, and the provision of family and peer support. Following discharge, patients will be required to adhere to their personalized exercise prescription and attend scheduled onsite follow-ups after discharge. The management model employed for this group is called home-based mobile guided exercise-based cardiac rehabilitation.

Behavioral: Home-based mobile guided exercise-based cardiac rehabilitation

The Routine-TAVR group

OTHER

Preparation for discharge will only involve an exercise endurance test and the guidance of an exercise prescription for the Routine-TAVR group. Following discharge, nurses will conduct monthly telephone follow-ups to check on the patient's progress. Additionally, patients will be scheduled for onsite follow-ups at the Outpatient Department.

Behavioral: Routine Care

Interventions

Discharge preparation, telerehabilitation, scheduled onsite follow-ups, telephone follow-ups, self-reporting, health education, online communication, family and peer support, mailing letters, institutional referrals, and security management.

The REHAB-TAVR group
Routine CareBEHAVIORAL

Discharge preparation, scheduled onsite follow-ups, telephone follow-ups

The Routine-TAVR group

Eligibility Criteria

Age60 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 60 years and ≤ 89 years old;
  • Patients scheduled to be discharged after TAVR;
  • Those who have the ability to read and write, and have normal speech and communication skills;
  • Patients and their families are willing to participate in this study;
  • Patients or family members have the ability to use mobile and an app.

You may not qualify if:

  • Serious complications occur before discharge (such as major bleeding, stroke, valve detachment, moderate or above perivalve leakage, coronary artery occlusion, etc.) ;
  • Patients who are unable to participate in postoperative exercise rehabilitation due to limb dysfunction;
  • Being in palliative care or treatment;
  • Those with other Contraindication to exercise-based cardiac rehabilitation (such as resting ECG changes indicating significant ischemia, acute myocardial infarction or other acute cardiac events, unstable angina, uncontrolled arrhythmia, heart failure decompensation, etc.);
  • Currently participating in other rehabilitation projects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Newman-Beinart NA, Norton S, Dowling D, Gavriloff D, Vari C, Weinman JA, Godfrey EL. The development and initial psychometric evaluation of a measure assessing adherence to prescribed exercise: the Exercise Adherence Rating Scale (EARS). Physiotherapy. 2017 Jun;103(2):180-185. doi: 10.1016/j.physio.2016.11.001. Epub 2016 Nov 9.

    PMID: 27913064BACKGROUND
  • Nagatomi Y, Ide T, Higuchi T, Nezu T, Fujino T, Tohyama T, Nagata T, Higo T, Hashimoto T, Matsushima S, Shinohara K, Yokoyama T, Eguchi A, Ogusu A, Ikeda M, Ishikawa Y, Yamashita F, Kinugawa S, Tsutsui H. Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty. ESC Heart Fail. 2022 Aug;9(4):2407-2418. doi: 10.1002/ehf2.13934. Epub 2022 May 9.

  • Shen Z, Mi S, Huang C, Zhou D, Pan W, Xu X, Lin Y, Zhang Y. Home-based mobile-guided exercise-based cardiac rehabilitation among patients undergoing transcatheter aortic valve replacement (REHAB-TAVR): protocol for a randomised clinical trial. BMJ Open. 2024 Mar 7;14(3):e080042. doi: 10.1136/bmjopen-2023-080042.

Study Officials

  • Zhiyun Shen

    Fudan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2023

First Posted

August 14, 2023

Study Start

September 1, 2023

Primary Completion

March 31, 2024

Study Completion

June 30, 2024

Last Updated

August 14, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share